A fluorobenzylcyclotetraphosphazene for the treatment of MCF-7 breast cancer, PC3 prostate cancer and HT29 colon cancer

What is AI technical title?
AI technical title is built by PatSnap AI team. It summarizes the technical point description of the patent document.
A fluorobenzylcyclotetraphosphazene compound effectively targets cancer stem cells, enhancing cancer treatment by inhibiting proliferation with minimal side effects on healthy cells, addressing the limitations of current therapies.

WO2026142684A1PCT designated stage Publication Date: 2026-07-02T C ANKARA UNIVERSITESI REKTORLUGU

0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: WO · WO
Patent Type: Applications
Current Assignee / Owner: T C ANKARA UNIVERSITESI REKTORLUGU
Filing Date: 2025-12-26
Publication Date: 2026-07-02

Smart Images

Figure TR2025051901_02072026_PF_FP_ABST

Patent Text Reader

Abstract

The invention relates to a fluorobenzylcyclotetraphosphazene compound having the structure of Formula I with antiproliferative effect against cancer, and the synthesis of this compound.

Need to check novelty before this filing date? Find Prior Art